DNA Treatment Could Delay Paralysis That Strikes Nearly All Patients with ALS
March 16, 2023
UC San Diego researchers use a DNA designer drug to restore key protein levels in motor neurons, delaying paralysis in a mouse model of ALS.
Your search for “neurodegenerative disease” returned 152 results
Gene Therapy Approach Shows Promise in Treating ALS
August 2, 2022
Researchers report that a gene therapy approach, developed at UC San Diego measurably delayed disease onset in humanized mouse and rat models of familial ALS, an inherited form of the disease that runs in families.
UC San Diego and UCLA Led UC System in Commercializing Inventions
August 2, 2018
UC San Diego and UCLA led the University of California system during the 2017 fiscal year in the number of commercial startups based on campus inventions, according to a report released this week by the University of California’s Office of the President.
UC San Diego’s William C. Mobley Recognized for Contributions to Down Syndrome
January 4, 2012
William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine and Chairman of the U.S. Scientific Advisory Committee of the Jérôme Lejeune Foundation, was recognized by U.S. Congressman Pete Sessions from the floor of the House of Representatives in…
Two from UCSD School of Medicine Named Members of the Institute of Medicine
October 15, 2012
The Institute of Medicine (IOM) today announced the names of 70 new members and 10 foreign associates during its 42nd annual meeting. Included are two new members from the University of California, San Diego School of Medicine: David A. Brenner, MD, vice chancellor for Health Sciences and dean of the…
Neuronal Structures Associated with Learning and Memory Sprout In Response to Novel Molecules
April 11, 2016
…that accumulates in the brains of people with Alzheimer’s disease.
One-Time Treatment Generates New Neurons, Eliminates Parkinson’s Disease in Mice
June 24, 2020
UC San Diego researchers have discovered that a single treatment to inhibit a gene called PTB in mice converts native astrocytes, brain support cells, into neurons that produce the neurotransmitter dopamine. As a result, the mice’s Parkinson’s disease symptoms disappear.
Identified Genetic Interaction Offers Possible New Target for Glaucoma Therapy
September 10, 2015
Scientists at the University of California, San Diego School of Medicine have elucidated a genetic interaction that may prove key to the development and progression of glaucoma, a blinding neurodegenerative disease that affects tens of millions of people worldwide and is a leading cause of irreversible blindness.
UC San Diego Cancer Biologist Receives Claugus Award for Medical Research
October 11, 2023
University of California San Diego cancer biologist Tatiana Hurtado de Mendoza has been named the recipient of the 2023 Claugus Award for Medical Research. The award was established in 2021 by the Foundation For A Better World.
Yishi Jin Named to Junior Seau Endowed Faculty Chair in Traumatic Brain Injury
March 8, 2018
The inaugural chair holder of the Junior Seau Foundation Endowed Chair in Traumatic Brain Injury at the University of California San Diego is Yishi Jin, Professor and Chair of the Section of Neurobiology in the Division of Biological Sciences. Jin’s research focuses on molecular genetic mechanisms underlying the development of…
